drugset / Trial / NCT02178644

Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer

NCT02178644 ↗

Phase 1 Completed 29 enrolled Yale University
NaSingle-groupOpen-labelTreatment

Summary

This pilot study focuses on KD018 and will investigate the effect of this agent on reducing the Gastrointestinal (GI) toxicity associated with combined modality therapy of locally-advanced rectal cancer.

Timeline

Start
2014-07
Primary completion
2019-09-20
Completion
2019-09-20

Drugs

EvaluationDrugModalityDoseRoute
Subject KD018 Traditional medicine (herbal / TCM) — —
Background Capecitabine Small molecule — —

Indications